{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:14:09Z","timestamp":1772770449503,"version":"3.50.1"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["R\/BMG\/PHY\/GMN\/20"],"award-info":[{"award-number":["R\/BMG\/PHY\/GMN\/20"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ashoka University"},{"DOI":"10.13039\/501100001502","name":"Department of Atomic Energy, Government of India","doi-asserted-by":"publisher","award":["RTI 4006"],"award-info":[{"award-number":["RTI 4006"]}],"id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>COVID-19 testing across India uses a mix of two types of tests. Rapid Antigen Tests (RATs) are relatively inexpensive point-of-care lateral-flow-assay tests, but they are also less sensitive. The reverse-transcriptase polymerase-chain-reaction (RT-PCR) test has close to 100% sensitivity and specificity in a laboratory setting, but delays in returning results, as well as increased costs relative to RATs, may vitiate this advantage. India-wide, about 49% of COVID-19 tests are RATs, but some Indian states, including the large states of Uttar Pradesh (pop. 227.9 million) and Bihar (pop. 121.3 million) use a much higher proportion of such tests. Here we show, using simulations based on epidemiological network models, that the judicious use of RATs can yield epidemiological outcomes comparable to those obtained through RT-PCR-based testing and isolation of positives, provided a few conditions are met. These are (a) that RAT test sensitivity is not too low, (b) that a reasonably large fraction of the population, of order 0.5% per day, can be tested, (c) that those testing positive are isolated for a sufficient duration, and that (d) testing is accompanied by other non-pharmaceutical interventions for increased effectiveness. We assess optimal testing regimes, taking into account test sensitivity and specificity, background seroprevalence and current test pricing. We find, surprisingly, that even 100% RAT test regimes should be acceptable, from both an epidemiological as well as a economic standpoint, provided the conditions outlined above are met.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1009126","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T13:26:08Z","timestamp":1626960368000},"page":"e1009126","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Optimizing testing for COVID-19 in India"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8597-2324","authenticated-orcid":true,"given":"Philip","family":"Cherian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0581-173X","authenticated-orcid":true,"given":"Sandeep","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5528-4002","authenticated-orcid":true,"given":"Gautam I.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"pcbi.1009126.ref001","unstructured":"Worldometers. India Coronavirus: 10,245,276 Cases and 148,470 Deaths\u2013Worldometer; 2020. Available from: https:\/\/www.worldometers.info\/coronavirus\/country\/india\/."},{"key":"pcbi.1009126.ref002","unstructured":"Menon GI. The Novel Coronavirus Variants and India\u2019s Uncertain Future; 2021. Available from: https:\/\/science.thewire.in\/health\/sars-cov-2-variants-b117-b1617-india-second-wave-uncertain-future\/."},{"issue":"1","key":"pcbi.1009126.ref003","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/ijmr.IJMR_3290_20","article-title":"Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020","volume":"152","author":"MV Murhekar","year":"2020","journal-title":"Indian Journal of Medical Research"},{"key":"pcbi.1009126.ref004","article-title":"Seroprevalence of SARS-CoV-2 in slums and non-slums of Mumbai, India, during June 29-July 19, 2020","author":"A Malani","year":"2020","journal-title":"medRxiv"},{"key":"pcbi.1009126.ref005","unstructured":"Delhi sero-survey results: Over 23% residents have coronavirus antibodies; 2020. Available from: https:\/\/www.livemint.com\/news\/india\/delhi-sero-survey-results-over-23-residents-have-coronavirus-antibodies-11595316584369.html."},{"key":"pcbi.1009126.ref006","unstructured":"Sharma M. 29% in Delhi developed Covid-19 antibodies, shows new sero survey; 2020. Available from: https:\/\/www.indiatoday.in\/india\/story\/delhi-covid-19-2nd-delhi-sero-survey-results-1713145-2020-08-20."},{"key":"pcbi.1009126.ref007","article-title":"Community prevalence of antibodies to SARS-CoV-2 and correlates of protective immunity in an Indian metropolitan city","author":"A Ghose","year":"2020","journal-title":"medRxiv"},{"key":"pcbi.1009126.ref008","article-title":"The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide survey in Karnataka, India","author":"GR Babu","year":"2020","journal-title":"medRxiv"},{"key":"pcbi.1009126.ref009","unstructured":"Sreevatsan A. How much of India is actually urban?; 2017. Available from: https:\/\/www.livemint.com\/Politics\/4UjtdRPRikhpo8vAE0V4hK\/How-much-of-India-is-actually-urban.html."},{"key":"pcbi.1009126.ref010","unstructured":"COVID19-India API; 2021. Available from: https:\/\/api.covid19india.org\/."},{"key":"pcbi.1009126.ref011","unstructured":"Menon S. Coronavirus: India tries new type of tests to tackle virus; 2020. Available from: https:\/\/www.bbc.com\/news\/world-asia-india-53609404."},{"key":"pcbi.1009126.ref012","unstructured":"Kopf D, Varathan P. If Uttar Pradesh were a country; 2017. Available from: https:\/\/qz.com\/india\/1094942\/if-uttar-pradesh-were-a-country-where-would-it-rank-by-size-wealth-and-other-measures\/."},{"key":"pcbi.1009126.ref013","unstructured":"Comparing Indian states and territories with countries: An Indian summary; 2020. Available from: https:\/\/www.economist.com\/content\/indian-summary."},{"key":"pcbi.1009126.ref014","unstructured":"UP, Bihar and Chhattisgarh keeping India backward: NITI Aayog CEO Amitabh Kant; 2018. Available from: https:\/\/www.businesstoday.in\/current\/economy-politics\/up-bihar-chhattisgarh-keeping-india-backward-niti-aayog-ceo-amitabh-kant\/story\/275483.html."},{"key":"pcbi.1009126.ref015","unstructured":"SDG India Index and Dashboard | iTech Mission; 2020. Available from: https:\/\/sdgindiaindex.niti.gov.in\/#\/ranking."},{"key":"pcbi.1009126.ref016","unstructured":"Indian Council of Medical Research. Information of Testing Strategies; 2020. Available from: https:\/\/www.icmr.gov.in\/cteststrat.html."},{"key":"pcbi.1009126.ref017","unstructured":"Kaul R. Rapid antigen tests account for close to 50% of Covid-19 tests in India: Govt data; 2020. Available from: https:\/\/www.hindustantimes.com\/health\/rapid-antigen-tests-account-for-close-to-50-of-covid-19-tests-in-india-govt-data\/story-WLh6mbgmXsZ92EBAA3zzBM.html."},{"key":"pcbi.1009126.ref018","unstructured":"Sirur S. It isn\u2019t just Delhi. Kerala, Bihar & UP also conduct more than 50% rapid antigen tests; 2020. Available from: https:\/\/theprint.in\/health\/it-isnt-just-delhi-kerala-bihar-up-also-conduct-more-than-50-rapid-antigen-tests\/550255\/."},{"key":"pcbi.1009126.ref019","article-title":"Field Evaluation of the Performance of a SARS-CoV-2 Antigen Rapid Diagnostic Test in Uganda using Nasopharyngeal Samples","author":"A Nalumansi","year":"2020","journal-title":"International Journal of Infectious Diseases."},{"key":"pcbi.1009126.ref020","article-title":"Clinical evaluation of the Roche\/SD Biosensor rapid antigen test with symptomatic, non-hospitalized patients in a municipal health service drive-through testing site","author":"Z Igl\u1f41i","year":"2020","journal-title":"medRxiv"},{"key":"pcbi.1009126.ref021","unstructured":"Gera I. Smell a RAT: The COVID-19 curve may not be flattening; 2020. Available from: https:\/\/www.financialexpress.com\/lifestyle\/health\/smell-a-rat-the-covid-19-curve-may-not-be-flattening\/2089431\/."},{"key":"pcbi.1009126.ref022","unstructured":"Menon S. Coronavirus: Is India\u2019s test and tracing strategy working?; 2020. Available from: https:\/\/www.bbc.com\/news\/world-asia-india-55083825."},{"key":"pcbi.1009126.ref023","unstructured":"Singh A. Difference in RT-PCR & RAT positivity rate | Indore News\u2014Times of India; 2020. Available from: https:\/\/timesofindia.indiatimes.com\/city\/indore\/difference-in-rt-pcr-rat-positivity-rate\/articleshow\/78883677.cms."},{"key":"pcbi.1009126.ref024","unstructured":"Banaji M. Bihar\u2019s COVID-19 Epidemic Is Not Over\u2014but Where Is It, Exactly?; 2020. Available from: https:\/\/science.thewire.in\/health\/bihar-covid-19-epidemic-cases-rapid-antigen-tests-positivity-death-surveillance-urbanisation-elections\/."},{"key":"pcbi.1009126.ref025","unstructured":"Bedi A. \u2018Results of 18 Nov RT-PCR tests awaited\u2019\u2014Covid surge sees delays, Delhi officials blame labs; 2020. Available from: https:\/\/theprint.in\/health\/results-of-18-nov-rt-pcr-tests-awaited-covid-surge-sees-delays-delhi-officials-blame-labs\/554510\/."},{"key":"pcbi.1009126.ref026","volume-title":"Modeling Infectious Diseases in Humans and Animals","author":"MJ Keeling","year":"2007"},{"key":"pcbi.1009126.ref027","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198805090.001.0001","volume-title":"Networks","author":"M Newman","year":"2018","edition":"2"},{"issue":"4","key":"pcbi.1009126.ref028","doi-asserted-by":"crossref","first-page":"e1000736","DOI":"10.1371\/journal.pcbi.1000736","article-title":"Dynamics and Control of Diseases in Networks with Community Structure","volume":"6","author":"M Salath\u00e9","year":"2010","journal-title":"PLOS Computational Biology"},{"issue":"7","key":"pcbi.1009126.ref029","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1073\/pnas.1008895108","article-title":"Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza","volume":"108","author":"S Cauchemez","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"pcbi.1009126.ref030","first-page":"1","article-title":"Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy","author":"G Giordano","year":"2020","journal-title":"Nature Medicine"},{"key":"pcbi.1009126.ref031","article-title":"The timing of COVID-19 transmission","author":"L Ferretti","year":"2020","journal-title":"medRxiv"},{"issue":"9","key":"pcbi.1009126.ref032","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/M20-0504","article-title":"The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application","volume":"172","author":"SA Lauer","year":"2020","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"pcbi.1009126.ref033","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3201\/eid2606.200357","article-title":"Serial Interval of COVID-19 among Publicly Reported Confirmed Cases","volume":"26","author":"Z Du","year":"2020","journal-title":"Emerging Infectious Diseases"},{"key":"pcbi.1009126.ref034","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijid.2020.02.060","article-title":"Serial interval of novel coronavirus (COVID-19) infections","volume":"93","author":"H Nishiura","year":"2020","journal-title":"International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases"},{"key":"pcbi.1009126.ref035","volume-title":"SARS-CoV-2, SARS-CoV-1 and MERS-CoV Viral Load Dynamics, Duration of Viral Shedding and Infectiousness: A Living Systematic Review and Meta-Analysis","author":"M Cevik","year":"2020"},{"key":"pcbi.1009126.ref036","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1017\/S0950268820001430","article-title":"Epidemiological characteristics of COVID-19: a systematic review and meta-analysis","volume":"148","author":"M Khalili","year":"2020","journal-title":"Epidemiology and Infection"},{"issue":"5","key":"pcbi.1009126.ref037","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M20-3012","article-title":"Prevalence of Asymptomatic SARS-CoV-2 Infection","volume":"173","author":"DP Oran","year":"2020","journal-title":"Annals of Internal Medicine"},{"key":"pcbi.1009126.ref038","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijid.2020.03.020","article-title":"Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)","volume":"94","author":"H Nishiura","year":"2020","journal-title":"International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases"},{"issue":"10","key":"pcbi.1009126.ref039","doi-asserted-by":"crossref","first-page":"2000180","DOI":"10.2807\/1560-7917.ES.2020.25.10.2000180","article-title":"Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020","volume":"25","author":"K Mizumoto","year":"2020","journal-title":"Eurosurveillance"},{"issue":"5","key":"pcbi.1009126.ref040","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","article-title":"Temporal dynamics in viral shedding and transmissibility of COVID-19","volume":"26","author":"X He","year":"2020","journal-title":"Nature Medicine"},{"key":"pcbi.1009126.ref041","volume-title":"Infectious Diseases of Humans: Dynamics and Control","author":"RM Anderson","year":"1992"},{"key":"pcbi.1009126.ref042","first-page":"85","volume-title":"Epidemic models: their structure and relation to data","author":"M C M de Jong","year":"1995"},{"key":"pcbi.1009126.ref043","doi-asserted-by":"crossref","first-page":"267049","DOI":"10.1155\/2011\/267049","article-title":"Pathogens, Social Networks, and the Paradox of Transmission Scaling","volume":"2011","author":"MJ Ferrari","year":"2011","journal-title":"Interdisciplinary Perspectives on Infectious Diseases"},{"key":"pcbi.1009126.ref044","article-title":"Is Covid-19 seroprevalence different in health care workers as per their risk of exposure? A study from a tertiary care hospital in National Capital Region of India","author":"S Kataria","year":"2021","journal-title":"medRxiv"},{"key":"pcbi.1009126.ref045","article-title":"Covid-19 related deaths among doctors in India","author":"A Kapoor","year":"2020","journal-title":"medRxiv"},{"key":"pcbi.1009126.ref046","unstructured":"SD Biosensor Test Specifications; 2020. Available from: https:\/\/www.who.int\/diagnostics_laboratory\/eual\/eul_0563_117_00_standard_q_covid19_ag_ifu.pdf."},{"key":"pcbi.1009126.ref047","unstructured":"Indian Council of Medical Research. Advisory on Strategy for COVID-19 Testing in India; 2020. Available from: https:\/\/www.mohfw.gov.in\/pdf\/AdvisoryonstrategyforCOVID19TestinginIndia.pdf."},{"key":"pcbi.1009126.ref048","article-title":"Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients","author":"E Kortela","year":"2020","journal-title":"medRxiv"},{"key":"pcbi.1009126.ref049","article-title":"Antigen-Based Testing but Not Real-Time Polymerase Chain Reaction Correlates With Severe Acute Respiratory Syndrome Coronavirus 2 Viral Culture","author":"A Pekosz","year":"2021","journal-title":"Clinical Infectious Diseases"},{"key":"pcbi.1009126.ref050","article-title":"Strategies for antigen testing: An alternative approach to widespread PCR testing","author":"SG Reddy","year":"2021","journal-title":"medRxiv"},{"key":"pcbi.1009126.ref051","unstructured":"How much do tests for Covid-19 cost in India? A state-wise breakup.; 2020. Available from: https:\/\/indianexpress.com\/article\/india\/covid-19-test-prices-rates-india-6896237\/."},{"key":"pcbi.1009126.ref052","unstructured":"Kumar R. Bihar caps cost of Covid RT-PCR test at Rs 800, down from Rs 1,500; 2020. Available from: https:\/\/www.hindustantimes.com\/india-news\/bihar-caps-cost-of-covid-rt-pcr-test-at-rs-800-down-from-rs-1-500\/story-BHgJliy7sFn2v8YCUNITyI.html."},{"key":"pcbi.1009126.ref053","unstructured":"COVID-19 antigen test cost capped at Rs 100 in Odisha; 2020. Available from: https:\/\/www.newindianexpress.com\/cities\/bhubaneswar\/2020\/dec\/22\/covid-19-antigen-test-cost-capped-at-rs-100-in-odisha-2239432.html."},{"key":"pcbi.1009126.ref054","article-title":"Rethinking Covid-19 Test Sensitivity\u2014A Strategy for Containment","author":"MJ Mina","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"pcbi.1009126.ref055","article-title":"Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance","author":"DB Larremore","year":"2020","journal-title":"medRxiv"},{"key":"pcbi.1009126.ref056","article-title":"Risk assessment via layered mobile contact tracing for epidemiological intervention","author":"V Guttal","year":"2020","journal-title":"medRxiv"},{"key":"pcbi.1009126.ref057","article-title":"The impact of high frequency rapid viral antigen screening on COVID-19 spread and outcomes: a validation and modeling study","author":"B Nash","year":"2020","journal-title":"medRxiv"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T13:26:57Z","timestamp":1626960417000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009126"}},"subtitle":[],"editor":[{"given":"Benjamin Muir","family":"Althouse","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":57,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1009126","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.12.31.20249106","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]}}}